Comments on: Congress Delays FDA Bill Until September http://www.pharmalot.com/2007/08/congress-delays-fda-bill-until-september/ News, Comment and Conversation Fri, 10 Feb 2012 18:21:37 +0000 http://wordpress.org/?v=2.6.2 By: Friday Blog Roundup « The Pump Handle http://www.pharmalot.com/2007/08/congress-delays-fda-bill-until-september/#comment-16250 Friday Blog Roundup « The Pump Handle Fri, 03 Aug 2007 16:05:54 +0000 http://www.pharmalot.com/2007/08/congress-delays-fda-bill-until-september/#comment-16250 [...] Ed Silverman at Pharmalot updates us on what’s happening with prescription drug legislation. [...] [...] Ed Silverman at Pharmalot updates us on what’s happening with prescription drug legislation. [...]

]]> By: Paul Haider http://www.pharmalot.com/2007/08/congress-delays-fda-bill-until-september/#comment-16169 Paul Haider Wed, 01 Aug 2007 22:12:31 +0000 http://www.pharmalot.com/2007/08/congress-delays-fda-bill-until-september/#comment-16169 Ed, With regard to PDUFA and Conflicts of Interests let me add something I came across regarding Provenge, and Dr. Howard Scher's affiliation with ProQuest Investments, a $1 billion venture capital fund, and PCF, Michael Milken's Prostate Cancer Foundation. Interestingly, Jonathan W. Simons, M.D., chief executive officer and president of the PCF is also 1 of 7 scientific advisors to ProQuest Investments. Interestingly, this notable appointment is lacking this bit of information on Dr. Simons ProQuest bio. http://www.prostatecancerfoundation.org/site/c.itIWK2OSG/b.2177291/k.5933/Top_Cancer_PhysicianScientist_Named_New_Head_of_the_Prostate_Cancer_Foundation.htm http://www.proquestvc.com/scienceadvisory.asp Dr. Howard Scher is one of eleven PCF consortium members and is 1 of 7 scienfic advisors to ProQuest Investments. PCF sure has a strong relationship to venture capital. How truly independent and benevolent is PCF? How much influence do they have over the FDA? Do you consider any ammendments to the PDUFA, similar to the Durbin Amendment, likely? Ed,
With regard to PDUFA and Conflicts of Interests let me add something I came across regarding Provenge, and Dr. Howard Scher’s affiliation with ProQuest Investments, a $1 billion venture capital fund, and PCF, Michael Milken’s Prostate Cancer Foundation. Interestingly, Jonathan W. Simons, M.D., chief executive officer and president of the PCF is also 1 of 7 scientific advisors to ProQuest Investments. Interestingly, this notable appointment is lacking this bit of information on Dr. Simons ProQuest bio.

http://www.prostatecancerfoundation.org/site/c.itIWK2OSG/b.2177291/k.5933/Top_Cancer_PhysicianScientist_Named_New_Head_of_the_Prostate_Cancer_Foundation.htm

http://www.proquestvc.com/scienceadvisory.asp

Dr. Howard Scher is one of eleven PCF consortium members and is 1 of 7 scienfic advisors to ProQuest Investments.

PCF sure has a strong relationship to venture capital. How truly independent and benevolent is PCF? How much influence do they have over the FDA? Do you consider any ammendments to the PDUFA, similar to the Durbin Amendment, likely?

]]>